148 related articles for article (PubMed ID: 37130467)
1. Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use.
Myers MG; Ganoczy D; Walters HM; Pfeiffer PN; Ilgen MA; Bohnert KM
Drug Alcohol Depend; 2023 Jun; 247():109876. PubMed ID: 37130467
[TBL] [Abstract][Full Text] [Related]
2. Screening for cannabis use disorder among young adults: Sensitivity, specificity, and item-level performance of the Cannabis Use Disorders Identification Test - Revised.
Coelho SG; Hendershot CS; Quilty LC; Wardell JD
Addict Behav; 2024 Jan; 148():107859. PubMed ID: 37717499
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users.
Loflin M; Babson K; Browne K; Bonn-Miller M
Am J Drug Alcohol Abuse; 2018; 44(1):19-23. PubMed ID: 29058471
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students.
Schultz NR; Bassett DT; Messina BG; Correia CJ
Addict Behav; 2019 Aug; 95():11-15. PubMed ID: 30798191
[TBL] [Abstract][Full Text] [Related]
5. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.
Matson TE; Lapham GT; Bobb JF; Oliver M; Hallgren KA; Williams EC; Bradley KA
JAMA Netw Open; 2022 Nov; 5(11):e2239772. PubMed ID: 36318205
[TBL] [Abstract][Full Text] [Related]
6. Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample.
Luquiens A; Berger-Viergat A; Larrieu A; Artigaud L; Fener C; Adamson S; Laprévote V; Rolland B
Drug Alcohol Rev; 2021 Nov; 40(7):1334-1339. PubMed ID: 33855757
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form.
Bonn-Miller MO; Heinz AJ; Smith EV; Bruno R; Adamson S
Cannabis Cannabinoid Res; 2016; 1(1):252-261. PubMed ID: 28861497
[No Abstract] [Full Text] [Related]
8. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
[TBL] [Abstract][Full Text] [Related]
9. Screen of drug use: Diagnostic accuracy for cannabis use disorder.
Tiet QQ; Leyva YE; Browne K; Moos RH
Addict Behav; 2019 Aug; 95():184-188. PubMed ID: 30933714
[TBL] [Abstract][Full Text] [Related]
10. Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study.
Sagar KA; Dahlgren MK; Smith RT; Lambros AM; Gruber SA
Cannabis; 2021; 4(2):47-59. PubMed ID: 37287530
[TBL] [Abstract][Full Text] [Related]
11. [Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review].
Artigaud L; Fener C; Bisch M; Schwan R; Schwitzer T; De Ternay J; Adamson SJ; Rolland B; Laprévote V
Encephale; 2020 Oct; 46(5):382-389. PubMed ID: 32475691
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal.
Lapham GT; Matson TE; Bobb JF; Luce C; Oliver MM; Hamilton LK; Bradley KA
JAMA Netw Open; 2023 Aug; 6(8):e2328934. PubMed ID: 37642968
[TBL] [Abstract][Full Text] [Related]
13. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use.
Shmulewitz D; Budney AJ; Borodovsky JT; Bujno JM; Walsh CA; Struble CA; Livne O; Habib MI; Aharonovich E; Hasin DS
J Psychiatr Res; 2023 Jul; 163():211-221. PubMed ID: 37224773
[TBL] [Abstract][Full Text] [Related]
14. From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans.
Serebro M; Sobol-Goldberg S; Feingold D
Front Psychiatry; 2021; 12():643618. PubMed ID: 34220568
[No Abstract] [Full Text] [Related]
15. The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health center.
Kelly SM; O'Grady KE; Gryczynski J; Mitchell SG; Kirk A; Schwartz RP
Subst Abus; 2017; 38(4):382-388. PubMed ID: 28686545
[TBL] [Abstract][Full Text] [Related]
16. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).
Adamson SJ; Kay-Lambkin FJ; Baker AL; Lewin TJ; Thornton L; Kelly BJ; Sellman JD
Drug Alcohol Depend; 2010 Jul; 110(1-2):137-43. PubMed ID: 20347232
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
Compton WM; Han B; Jones CM; Blanco C
Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care.
Levy S; Weitzman ER; Marin AC; Magane KM; Wisk LE; Shrier LA
Subst Abus; 2021; 42(3):388-395. PubMed ID: 32814009
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.
Livingston NA; Farmer SL; Mahoney CT; Marx BP; Keane TM
Psychol Addict Behav; 2022 Mar; 36(2):131-143. PubMed ID: 34351175
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Criteria to Screen for Cannabis Use Disorder.
Casajuana C; López-Pelayo H; Miquel L; Balcells-Oliveró MM; Colom J; Gual A
Eur Addict Res; 2018; 24(3):109-117. PubMed ID: 29949807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
